Jordi Moya
Minorca, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction to: Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication.
Journal: Drugs in R&D
Published: July 11, 2018
Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication.
Journal: Drugs in R&D
Published: March 25, 2018
Breakthrough Pain Management with Sublingual Fentanyl Tablets in Patients with Cancer: Age Subgroup Analysis of a Multicenter Prospective Study.
Journal: Drugs in R&D
Published: July 27, 2017
Erratum to: Sublingual Fentanyl Tablets for Relief of Breakthrough Pain in Cancer Patients and Association with Quality-of-Life Outcomes.
Journal: Clinical drug investigation
Published: June 04, 2016
Sublingual Fentanyl Tablets for Relief of Breakthrough Pain in Cancer Patients and Association with Quality-of-Life Outcomes.
Journal: Clinical drug investigation
Published: October 29, 2015
Efficacy and Safety of Oral or Nasal Fentanyl for Treatment of Breakthrough Pain in Cancer Patients: A Systematic Review.
Journal: Journal of pain & palliative care pharmacotherapy
Published: October 13, 2015
Efficacy and safety of sublingual fentanyl orally disintegrating tablets in patients with breakthrough pain: multicentre prospective study.
Journal: Clinical drug investigation
Published: July 25, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026